The Clorox Company (NYSE:CLX) is Liberty One Investment Management LLC’s 3rd Largest Position

Liberty One Investment Management LLC lessened its holdings in The Clorox Company (NYSE:CLX) by 0.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 196,039 shares of the company’s stock after selling 897 shares during the period. Clorox comprises approximately 3.4% of Liberty One Investment Management LLC’s holdings, making the stock its 3rd biggest holding. Liberty One Investment Management LLC’s holdings in Clorox were worth $31,839,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp boosted its holdings in Clorox by 3.1% in the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after acquiring an additional 245,525 shares during the period. Mizuho Securities USA LLC lifted its position in shares of Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after purchasing an additional 33,970 shares during the period. Stifel Financial Corp grew its holdings in Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after purchasing an additional 37,967 shares in the last quarter. Finally, Van ECK Associates Corp increased its stake in Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after buying an additional 31,510 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Down 0.1 %

Clorox stock opened at $160.31 on Friday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The firm’s 50-day moving average is $164.25 and its 200-day moving average is $156.38. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company has a market cap of $19.84 billion, a P/E ratio of 55.86, a PEG ratio of 2.90 and a beta of 0.42.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox’s revenue was up 27.0% on a year-over-year basis. During the same quarter last year, the company posted $0.49 earnings per share. On average, equities analysts expect that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.04%. Clorox’s payout ratio is currently 170.04%.

Wall Street Analysts Forecast Growth

CLX has been the subject of a number of analyst reports. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $155.00 to $157.00 in a research report on Tuesday, January 7th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Evercore ISI dropped their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Barclays reduced their target price on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday. Finally, JPMorgan Chase & Co. lifted their price target on shares of Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research note on Thursday. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.